T1	Participants 518 537	Ninety-six patients
T2	Participants 198 288	One hundred and eleven previously untreated patients with extensive small cell lung cancer
T3	Participants 518 623	Ninety-six patients were evaluable for response and toxicity and additional 12 patients for toxicity only
